Evidence map›Paper›PMID 42334219›Full record

ArticleJournal of clinical microbiology2026

Increased sensitivity of the updated FluoroType MTBDR V2 with addition of IS

Erik Svensson, Dorte Bek Folkvardsen, Anders Norman, Erik Michael Rasmussen, Troels Lillebaek

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Erik SvenssonInternational Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0003-0797-1080
Dorte Bek FolkvardsenInternational Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0002-6430-4586
Anders NormanInternational Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0002-1282-394X
Erik Michael RasmussenInternational Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0002-4401-7598
Troels LillebaekInternational Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0002-2601-2718

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) remains a major global health challenge, requiring rapid, reliable molecular tests to detect the

Indexed as

DNA Transposable ElementsMolecular Diagnostic TechniquesMycobacterium tuberculosisTuberculosis, Multidrug-ResistantAntitubercular AgentsDNA, BacterialDrug Resistance, Multiple, BacterialHumansProspective StudiesSensitivity and SpecificityWhole Genome SequencingAntitubercular AgentsDNA, BacterialDNA Transposable Elementsdrug-resistant tuberculosisFluoroType MTBDRIS6110moderate-complexity automated nucleic acid amplification testsMycobacterium tuberculosis complexpaucibacillary tuberculosis

Identifiers

PMID42334219
PMCPMC13463815

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.